Catapult hires new investment manager

King joins Catapult from Critical Pharmaceuticals, a Catapult life sciences portfolio company, where he was CEO for the last four years. The VC hired him to launch its new life sciences fund for the Greater Manchester and Cheshire region.

Catapult's GM&C Life Sciences Fund is a seed and early-stage venture capital vehicle which reached a first close at £31m.

King, a former research fellow at Harvard Medical School, started his career as a bioinformatics project manager at pharmaceutical company AstraZeneca in 1997. He later worked with the business development team of Incyte, a Californian genomics company; as commercial director for pharmaceutical company Cyprotex; and vice-president of business development at clinical research organisation Pharmaceutical Profiles.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• People
• UK / Ireland
• Venture
• people moves